Feeley Kevin (CIK 1944119) reported 114 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-18). Recent activity: Buy WGS (7,197 shares), Sell WGS (760 shares), Sell WGS (2,106 shares), Sell WGS (863 shares), Buy WGS (2,462 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 7,197 | $0 |
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 760 | $45,413 |
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 2,106 | $128,106 |
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 863 | $53,078 |
| 2026-06-11 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 2,462 | $0 |
| 2026-06-11 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 1,266 | $68,073 |
| 2026-06-03 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 717 | $0 |
| 2026-06-03 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 369 | $19,092 |
| 2026-05-01 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 392 | $25,555 |
| 2026-05-01 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 754 | $0 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 16,250 | $0 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 2,485 | $152,306 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 2,520 | $159,466 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 995 | $64,277 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 1,857 | $121,095 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 961 | $59,899 |
| 2026-03-17 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 3,815 | $0 |
| 2026-03-17 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 7,197 | $0 |
| 2026-03-17 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 2,384 | $182,018 |
| 2026-03-17 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 3,065 | $236,158 |
| 2026-03-17 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 257 | $20,031 |
| 2026-03-11 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 2,462 | $0 |
| 2026-03-11 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 1,280 | $111,040 |
| 2026-03-09 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 1,986 | $174,986 |
| 2026-03-05 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 15,262 | $0 |
Source: SEC Form 4 filings · as of 2026-06-18